New reimbursement guideline for hepatitis B drug to be drafted

The government said Tuesday it will establish a new guideline for the reimbursement of hepatitis B drugs, such as Viread, Hepsera, Baraclude and Zeffix.

Under the guideline, Viread can be reimbursed in patients with HIV-1 infection and chronic hepatitis B and its cocktail therapy is allowed with restriction, but co-administration of Viread with Hepsera or other interferon drugs are not reimb...